SCHOTT Poonawalla Begins Work on $400 Million India Facility
· Business · Moneycontrol
SCHOTT Poonawalla has begun construction on a new $400 million manufacturing facility in India to expand its production of pharmaceutical packaging. The joint venture is backed by Germany-based SCHOTT Pharma and India-based TPG Growth. The plant will produce advanced containment solutions, including vials, syringes, and ampoules, to supply domestic and international drug makers. Construction timelines and specific location details within India were part of the initial rollout announcements. The investment underscores growing global demand for high-grade medical packaging and local manufacturing capabilities.
Why it matters
The new manufacturing facility will expand the local supply of critical pharmaceutical packaging materials for drug makers operating in India and export markets.
Read the original report — Moneycontrol
Join us on Telegram
Breaking news the moment it lands. At 10,000 members we ship the Android app.